Hyperlipoproteinemia Type III
Links shared publicly online about this topic
Hyperlipoproteinemia Type III on #MDlinx
mdlinx.com — “Hyperlipoproteinemia Type III on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 12, 2010 at 11:40 pm By:
Update of the Portuguese Familial Hypercholesterolaemia Study: Atherosclerosis http://bit.ly/c7BJgg #cardiology
Cardiology Article | Hyperlipoproteinemia Type III
mdlinx.com — “Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on November 12, 2010 at 4:26 pm By:
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia: Vasc... http://bit.ly/anRqWz #cardiology
Endocrinology Article | Hyperlipoproteinemia Type III
mdlinx.com — “Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on November 12, 2010 at 1:29 am By:
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia: Vascular H... http://bit.ly/aaDzSy #endo
Cardiology Article | Hyperlipoproteinemia Type III
mdlinx.com — “Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprotein apheresis” View full resource at mdlinx.com
Most Recently Shared on November 2, 2010 at 6:35 am By:
Familial hypercholesterolemia: Current treatment options and patient selection for low-density lipoprot... http://bit.ly/cVuGBI #cardiology
Cardiology Medical News about Hyperlipoproteinemia Type III
mdlinx.com — “Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholesterol in Patients With Familial Hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on May 12, 2010 at 6:28 am By:
Effect of Mipomersen, an Apolipoprotein B Synthesis Inhibitor, on Low-Density Lipoprotein Cholester... http://bit.ly/98oxLx #cardio #mdlinx
Cardiology Medical News about Hyperlipoproteinemia Type III
mdlinx.com — “Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for type III hyperlipoproteinemia” View full resource at mdlinx.com
Most Recently Shared on April 1, 2010 at 11:55 am By:
Non-HDL-cholesterol/apolipoprotein B ratio: A useful distinguishing feature in the screening for ty... http://bit.ly/ch4kt7 #cardio #mdlinx
Cardiology Medical News about Hyperlipoproteinemia Type III
mdlinx.com — “Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients” View full resource at mdlinx.com
Most Recently Shared on May 26, 2010 at 12:51 am By:
Carotid Atherosclerosis Progression in Familial Hypercholesterolemia Patients: Circulation: Cardiov... http://bit.ly/aFRHmf #cardio #mdlinx
Internal Medicine Article | Hyperlipoproteinemia Type III
mdlinx.com — “Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on November 11, 2010 at 10:52 am By:
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia: Vascul... http://bit.ly/9yTPka #medicine
Family Medicine Article | Hyperlipoproteinemia Type III
mdlinx.com — “Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on November 13, 2010 at 11:41 pm By:
Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia: Vas... http://bit.ly/d0FsIP #FamPractice
Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia
peerview-institute.org — “Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia” View full resource at peerview-institute.org
Most Recently Shared on January 25, 2011 at 1:47 pm By:
Disappearance of Angina Pectoris by Lipid-Lowering in Type III Hyperlipoproteinemia http://goo.gl/B5Jsf
Pediatrics Medical News about Hyperlipoproteinemia Type II Colesevelam
mdlinx.com — “Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia” View full resource at mdlinx.com
Most Recently Shared on March 24, 2010 at 4:23 pm By:
Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia: Pediatric Drugs http://bit.ly/cMzHp8 #peds
Glycogen Storage Disease, Type III: eMedicine Endocrinology
emedicine.medscape.com — “Overview: A glycogen storage disease (GSD) results from the absence of enzymes that ultimately convert glycogen compounds to glucose. Enzyme deficiency results in glycogen accumulation in tissues. In many cases, the defect has systemic consequences, but, in ...” View full resource at emedicine.medscape.com
Most Recently Shared on May 5, 2010 at 7:02 pm By:
Type III glycogen storage disease is also called Forbes-Cori disease, & is a result of debranching enzyme deficiecy. http://bit.ly/aGgc9e
Polyglandular Autoimmune Syndrome, Type III: eMedicine Endocrinology
emedicine.medscape.com — “Overview: Polyglandular autoimmune syndrome (PAS) is made up of a group of autoimmune disorders of the endocrine glands.1 The syndrome results in failure of the glands to produce their hormones. Glandular abnormalities of the endocrine ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 14, 2010 at 3:20 am By:
Type 2 polyglandular autoimmune syndrome is made up of a group of autoimmune disorders of the endocrine glands. http://bit.ly/bhgYu5
Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb Spasticity
medicalnewstoday.com — “Data results published this month in Clinical Neuropharmacology, revealed that Merz Pharmaceuticals' NT 201 (botulinum toxin type A free from complexing proteins), also known by the brand n” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2009 at 1:59 pm By:
Merz Pharmaceuticals Announces Phase III Data For NT 201 In Post-stroke Upper Limb Spasticity: Data results pub.. http://bit.ly/1aaB36
FDA Grants Type B Meeting To Be Held November 8, 2010 To Discuss Phase III Protocols For Androxal(R)
medicalnewstoday.com — “Repros Therapeutics Inc.® (NasdaqCM:RPRX) announced that the Company has been granted a Type B meeting to be held on November 8, 2010 with the Division of Reproductive and Urologic Products to” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 1:05 pm By:
FDA Grants Type B Meeting To Be Held November 8, 2010 To Discuss Phase III Protocols For Androxal(R) http://mnt.to/3KNx #fertility
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

